Health tech startup Carelane sets new standards for clinical research with AI-driven, end-to-end platform

Seed funding of EUR 2.6 million led by Vorwerk Ventures

07-Jul-2025 - As clinical studies are always increasing in complexity, research institutions’ software solutions remain fragmented and outdated. Carelane has developed an end-to-end platform that integrates all phases of a study, from protocol development to data analysis. Their innovative approach combines ...

Siemens completes acquisition of Dotmatics

Acquisition expanding Siemens’ offerings into the life sciences industry

03-Jul-2025 - Siemens AG announced today that it has completed the acquisition of Dotmatics, a leading provider of Life Sciences R&D software headquartered in Boston and portfolio company of global software investor Insight Partners, for an enterprise value of $5.1 billion. With the transaction now completed, ...

SARS-CoV-2: Cell phone and genome data allow targeted tracing of infection pathways

Scientists from the Jena start-up nanozoo GmbH and Jena University Hospital present analysis

28-Jan-2025 - To track the spread of pathogens such as SARS-CoV-2 in a more targeted manner, anonymized mobile phone data and other metadata (such as zip codes) can be combined with genome data. A systematic evaluation of such combined data pools has now been presented by scientists from the Jena-based ...

A key to analyzing millions of individual cells

Artificial intelligence in biomedicine

27-Jan-2025 - Our bodies are made up of around 75 billion cells. But what function does each individual cell perform and how greatly do a healthy person’s cells differ from those of someone with a disease? To draw conclusions, enormous quantities of data must be analyzed and interpreted. For this purpose, ...

Eppendorf SE and DataHow AG announce strategic collaboration to advance bioprocess data management

04-Dec-2024 - Eppendorf SE, a leading life science company, and DataHow AG, a pioneer in advanced data analytics and AI-driven prediction software, are excited to announce a strategic collaboration aimed at transforming bioprocess development. This partnership will integrate DataHow's innovative AI-enabled ...

Artificial intelligence is drastically changing the healthcare sector

Companies are engaging with AI and investing in it, but only 29 percent feel well prepared to use GenAI for competitive advantage

25-Nov-2024 - The global healthcare sector is beset by challenges such as cost pressure, a shortage of qualified staff and regulatory requirements. Artificial intelligence (AI), including generative artificial intelligence (GenAI), offers a solution. Executives in the industry share this view, as a survey of ...

A New Open-Source Tool for Analyzing Complex Health Data

Sort, group, and analyze large, heterogeneous, and complex datasets without any pre-existing hypotheses

13-Sep-2024 - Led by Helmholtz Munich, scientists have developed an accessible software solution specifically designed for the analysis of complex medical health data. The open-source software called “ehrapy” enables researchers to structure and systematically examine large, heterogeneous datasets. The ...

Making sense of the data jungle

A research team develops a tool for visualizing single-cell data

01-Aug-2024 - Modern cutting-edge research generates enormous amounts of data, presenting scientists with the challenge of visualizing and analyzing it. Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the Technical University of Applied Sciences ...

AI personalises brain tumour therapy

Progress in the personalised treatment of brain tumours: AI identifies mutations

22-May-2024 - Machine learning (ML) methods can quickly and accurately diagnose mutations in gliomas – primary brain tumours. This is shown by a recent study by Karl Landsteiner University of Health Sciences (KL Krems). In this study, data from physio-metabolic magnetic resonance images were analysed to ...

Revolution in the pharmaceutical industry? Swiss startup launches AI-based software for clinical trials

Protocol AI accelerates clinical trial development and patient access to therapies

30-Apr-2024 - Risklick, a spin-off from the University of Bern, launched Protocol AI, the first software of its kind, marking a turning point in the pharmaceutical industry. Utilizing artificial intelligence, Protocol AI accelerates clinical trial development, reduces costs, and enhances safety standards. This ...